"Chen, Chao-Yin" . . "Kirshenbaum, H." . . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "Solomon, Scott" . "21" . . "I, N" . "301639" . . "Eckardt, Kai-Uwe" . "Magana, A." . "Ivanovich, Peter" . "Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested." . . . . . "Parfrey, Patrick" . "Kvapil, Milan" . "stage renal-disease; erythropoiesis-stimulating agents; recombinant human erythropoietin; randomized-trials; cardiovascular-disease; hemodialysis-patients; anemia correction; clinical-trials; epoetin-alpha; risk-factor"@en . "14"^^ . "804"^^ . "Kramer, S." . "McGill, Janet" . "Pfeffer, Marc" . "Toto, Robert" . "A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease"@en . "000271898600007" . "Zeeuw, Dick" . "Parving, Hans-Henrik" . "Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested."@en . "Cooper, Mark E" . "RIV/00216208:11130/09:6882" . "Remuzzi, Giuseppe" . . "[16C922052C81]" . "Feyzi, Jan" . . "A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease"@en . "Levey, Andrew" . "A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease" . "A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease" . "1"^^ . . . "0028-4793" . . "Burdmann, Emmanuel" . "New England Journal of Medicine" . "McMurray, John" . . "Kewalramani, Reshma" . . "11130" . . "Singh, Ajay" . "http://www.ncbi.nlm.nih.gov/pubmed/19880844" . . . "Lewis, Eldrin" . "RIV/00216208:11130/09:6882!RIV13-MSM-11130___" . . . "361" .